VIRTUAL EVENT
IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.
IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.
By signing up, you’re agreeing to receive email from SCB. But rest assured: we respect your privacy.